Stock Report

Download full stock data and analysis for free Last Updated: 24-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Axsome Therapeutics (AXSM) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$145.96

up-down-arrow $-10.11 (-6.48%)

As on 23-Oct-2026 13:33EDT

Market cap

info icon

$8,231 Mln

Revenue (TTM)

info icon

$777 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

121.6

Div. Yield

info icon

0 %

Edit peer-selector-edit
Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Market cap ($ Mln)
 8,231 12,979 11,908 11,248 11,022
Revenue ($ Mln)
 777 713 831 5,020 332,834
Net Profit ($ Mln)
 -191.64 -696.24 54.90 -199.00 33,166.55
Net Margin (%)
 -24.68 -97.64 6.61 -3.96 9.96
RoE (%)
 -223.36 -- 8.11 -3.03 8.88
Price to Earnings
 -- -- 244.80 -- 30.07
Price-To-Book
 121.64 123.68 18.00 1.73 2.58

Income Statement ($ Mln)

Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Operating Revenue arrow
776.57 713.07 830.81 5,020.00 332,834.17
Cost of Revenue arrow
52.53 47.45 14.09 2,380.00 165,910.29
Gross Profit arrow
591.02 473.81 748.43 2,050.00 190,428.00
Operating Expenses arrow
912.58 1,209.09 810.32 2,178.00 131,728.10
Operating Profit (EBIT) arrow
-188.54 -543.47 6.41 462.00 35,195.77
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
-191.09 -706.17 26.37 -166.00 41,359.76
Provision for Tax arrow
0.56 -7.73 -35.26 33.00 8,582.66
Profit after Tax (Net Income) arrow
-191.64 -696.24 54.90 -199.00 33,166.55
Minority Interest arrow
0.00 10.15 0.00 0.00 389.00
Consolidated Profit arrow
0.00 0.00 0.00 0.00 25,570.00

Liabilities ($ Mln)

Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Shareholder's Funds arrow
83.30 -2,515.22 705.78 6,588.00 383,428.00
Minority Interest arrow
0.00 10.15 0.00 0.00 389.00
Non-Current Liabilities arrow
217.70 2,832.54 29.12 5,121.00 31,229.00
Current Liabilities arrow
460.45 890.65 153.80 1,852.00 157,341.00
Total Liabilities arrow
689.81 936.03 836.65 13,358.00 492,989.00

Assets ($ Mln)

Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Non-Current Assets arrow
104.88 124.16 449.03 9,764.00 275,974.00
Current Assets arrow
656.57 1,093.14 439.68 3,797.00 299,331.00
Total Assets arrow
689.81 936.03 836.65 13,358.00 492,989.00
Total Debt* arrow
219.21 2,493.78 9.42 3,918.00 71,952.00
Net Current Assets arrow
196.12 202.49 285.87 1,945.00 141,990.00

Cashflow ($ Mln)

Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Cash From Operating Activities arrow
-93.41 -445.91 142.00 560.00 46,428.00
Cash Flow from Investing Activities arrow
-0.48 -24.49 69.76 -279.00 -58,077.00
Cash from Financing Activities arrow
101.47 359.29 -220.37 -275.00 18,911.00
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
ROCE (%) arrow
-63.21 -159.44 14.87 -2.21 16.61
ROE (%) arrow
-223.36 41.15 8.11 -3.03 8.88
ROA (%) arrow
-17.39 -41.39 5.52 -1.30 4.76
EBIT Margin (%) arrow
-23.96 -86.43 3.17 1.61 11.97
Net Margin (%) arrow
-24.68 -97.64 6.61 -3.96 9.96
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Revenue Growth (%) arrow
56.87 202.39 16.02 11.95 -0.43
EBIT Growth (%) arrow
21.50 5.05 -79.11 -90.61 -50.25
Net Profit Growth (%) arrow
22.38 10.33 -58.66 -145.85 -41.61
EPS Growth (%) arrow
25.75 12.58 -62.44 -146.42 -41.56
Book Value Growth (%) arrow
9.44 -36.90 12.98 -3.87 9.58

Valuation Ratios

 Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Price / Earnings arrow
-50.48 -20.69 41.86 -48.47 0.19
Price / Book Value arrow
104.73 -7.27 6.44 1.73 2.58
Dividend Yield (%) arrow
-- -- -- 0.00 0.63
EV/EBITDA arrow
-54.53 -25.47 55.67 19.02 0.01
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Debt to Equity arrow
1.42 -0.77 0.00 0.58 0.00
Short term debt to equity ratio arrow
0.85 -0.22 0.00 0.01 0.16
Current Ratio arrow
1.43 1.23 2.86 2.05 1.90
Quick Ratio arrow
1.34 1.17 2.77 1.10 1.39
Interest Coverage arrow
-37.09 -6.86 -- 0.36 10.86

Operating Efficiency Ratios

 Axsome Therapeutics (AXSM) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Debtors to sales (%) arrow
35.73 35.69 9.26 22.95 37.38
Asset Turnover arrow
0.70 0.42 0.84 0.33 0.48
Receivable days arrow
104.82 52.44 28.27 70.73 115.08
Inventory Days arrow
167.98 172.81 355.76 226.89 181.99
Payable days arrow
529.03 296.14 785.55 45.50 56.23
Cash Conversion Cycle arrow
-256.23 -70.89 -401.52 252.12 240.84
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...